| Name | Title | Contact Details |
|---|---|---|
Linda Warshavsky |
Assistant General Counsel | Profile |
Katie Atkins |
Vice President, Senior Associate General Counsel | Profile |
Shawn Verner |
General Counsel and Chief Compliance Officer | Profile |
Adam Mcananey |
Chief Legal Officer and Secretary | Profile |
Karen Abbott |
Chief Administrative Officer and Chief Compliance Officer | Profile |
Chinese Community Health Plan is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
WellBe® is a digital health platform that provides voice-activated assistance with health questions, reminders, and entertainment using a smart speaker.
Npl Home Care Inc is a Elyria, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Designated “Best of Nursing Homes 2019-2020 - Highest Performing Short-Term Stay” by U.S. News and World Report (Bloomingdale, Chicago Ridge, Elmhurst, La Grange, Lake Zurich, Lombard, Schaumburg) Designated “Best of Nursing Homes 2020” by Newsweek (Bloomingdale) Winner of McKnight`s Long-Term Care News Excellence in Technology "2017 Gold Innovator of the Year" for Curatess Telemedicine Platform Awarded "Best"/Top Performer by U.S. News and World Report: Lexington Health Care Center of Elmhurst Lexington Health Network is Chicagoland`s premier provider of post-acute care & rehabilitation, long-term care, memory care, independent & assisted living, home health care, hospice care and private duty nursing. As the leader of integrated health services, Lexington Health Network is with you, from hospital to home and beyond. Today, Lexington Health Network manages more than 2,000 skilled nursing beds in 10 different post hospital, nursing and long term care buildings as well as more than 500 independent retirement units and more than 150 assisted living units within 3 senior living centers. Our diverse network of health care services also offers home health care, hospice care and private care services. Lexington proudly employs more than 2,500 full and part time individuals enabling us to provide an immeasurable value to the communities we serve. So much of who we are comes from an integrated organization dedicated to the highest attainable quality of care available today. As a family-owned organization, we have always maintained a unique perspective. Whether you are a post-acute patient, resident, a family member, or an employee, you are considered an extension of our family. In an industry filled with rapid change and growth, the Lexington constant, of our commitment to family values, will never change. Welcome to the Lexington Health Network.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.